ARTICLE | Company News
Competitive Technologies Inc., Genzyme deal
January 2, 2006 8:00 AM UTC
CTT granted GENZ a license to U.S. Patent No. 4,940,658 covering homocysteine tests. CTT will receive an upfront payment and is eligible for royalties. Homocysteine is a marker for cardiovascular and ...